Advertisement
UK markets close in 3 hours 1 minute
  • FTSE 100

    8,102.66
    +62.28 (+0.77%)
     
  • FTSE 250

    19,741.73
    +22.36 (+0.11%)
     
  • AIM

    755.79
    +1.10 (+0.15%)
     
  • GBP/EUR

    1.1667
    +0.0022 (+0.19%)
     
  • GBP/USD

    1.2505
    +0.0043 (+0.35%)
     
  • Bitcoin GBP

    51,166.97
    -2,129.59 (-4.00%)
     
  • CMC Crypto 200

    1,362.90
    -19.68 (-1.42%)
     
  • S&P 500

    5,071.63
    +1.08 (+0.02%)
     
  • DOW

    38,460.92
    -42.77 (-0.11%)
     
  • CRUDE OIL

    83.24
    +0.43 (+0.52%)
     
  • GOLD FUTURES

    2,338.20
    -0.20 (-0.01%)
     
  • NIKKEI 225

    37,628.48
    -831.60 (-2.16%)
     
  • HANG SENG

    17,284.54
    +83.27 (+0.48%)
     
  • DAX

    18,004.45
    -84.25 (-0.47%)
     
  • CAC 40

    8,028.19
    -63.67 (-0.79%)
     

1 "Safe" Stock to Avoid and 1 to Consider Buying in April

1 "Safe" Stock to Avoid and 1 to Consider Buying in April

Many investors have had the unpleasant experience of buying shares of a company they thought was safe, only to see their money evaporate down the line when their investment wasn't as "safe" as their initial impressions. In that vein, one of the hallmarks of safety is reliable and highly recurring revenue and earnings, complete with a durable and defensible profit margin that's consistent over time. Manufacturers of generic pharmaceuticals seem to fit that bill.